Peter Mezes
19Patents
10h-index
62Co-inventors
75Inventor score
Filing activity: Aug 21, 1992 → Jan 20, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5892020A | Multivalent single chain antibodies | Chemistry; Metallurgy | 127 | Expired |
| US5877291A | Multivalent single chain antibodies | Chemistry; Metallurgy | 101 | Expired |
| US6071515A | Dimer and multimer forms of single chain polypeptides | Chemistry; Metallurgy | 84 | Expired |
| US6329507A | Dimer and multimer forms of single chain polypeptides | Chemistry; Metallurgy | 77 | Expired |
| US6030792A | Assays for measurement of protein fragments in biological media | Emerging Cross-Sectional Technologies | 53 | Expired |
| US5472693A | Family of anti-carcinoembryonic antigen chimeric antibodies | Chemistry; Metallurgy | 43 | Expired |
| US8067544B2 | Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof | Physics | 26 | Active |
| US5976531A | Composite antibodies of human subgroup IV light chain capable of binding to tag-72 | Chemistry; Metallurgy | 26 | Expired |
| US6495137B1 | Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5976845A | Composite antibodies of human subgroup IV light chain capable of binding to TAG-72 | Chemistry; Metallurgy | 14 | Expired |
| US5993813A | Family of high affinity, modified antibodies for cancer treatment | Chemistry; Metallurgy | 10 | Expired |
| US7141549B2 | Proteins and nucleic acids encoding same | Human Necessities | 5 | Expired |
| US5808033A | Family of anti-carcinoembryonic antigen chimeric antibodies | Chemistry; Metallurgy | 5 | Expired |
| US8846873B2 | Antibodies directed to GPNMB and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US6207815A | Family of high affinity, modified antibodies for cancer treatment | Chemistry; Metallurgy | 4 | Expired |
| US7179899B2 | Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72 | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6051225A | Family of high affinity, modified antibodies for cancer treatment | Chemistry; Metallurgy | 2 | Expired |
| US9580503B2 | Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof | Physics | 0 | Active |
| US6641999B1 | Probing method for identifying antibodies specific for selected antigens | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.